Updated Jul 16, 2026
Abate Kristin has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $11K.
Kristin Abate is the Chief Accounting Officer at Karyopharm Therapeutics Inc., a pharmaceutical company focused on cancer therapies. She has been involved in multiple SEC filings related to her role, indicating her active participation in the company's financial reporting.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-15 | KPTI | Karyopharm Therapeutics Inc. | S — Open-market sale | 53 | $9.50 | $504 |
| 2026-05-15 | KPTI | Karyopharm Therapeutics Inc. | A — Grant or award | 121 | $0.00 | |
| 2026-03-03 | KPTI | Karyopharm Therapeutics Inc. | S — Open-market sale | 559 | $9.41 | $5K |
| 2026-01-29 | KPTI | Karyopharm Therapeutics Inc. | S — Open-market sale | 50 | $7.03 | $352 |
| 2026-01-29 | KPTI | Karyopharm Therapeutics Inc. | A — Grant or award | 92 | $0.00 | |
| 2026-01-22 | KPTI | Karyopharm Therapeutics Inc. | S — Open-market sale | 265 | $5.96 | $2K |
| 2025-10-15 | KPTI | Karyopharm Therapeutics Inc. | A — Grant or award | 12.8K | $0.00 | |
| 2025-10-01 | KPTI | Karyopharm Therapeutics Inc. | S — Open-market sale | 362 | $6.30 | $2K |
| 2025-09-12 | KPTI | Karyopharm Therapeutics Inc. | S — Open-market sale | 23 | $6.43 | $148 |
| 2025-09-12 | KPTI | Karyopharm Therapeutics Inc. | A — Grant or award | 46 | $0.00 | |
| 2025-09-03 | KPTI | Karyopharm Therapeutics Inc. | S — Open-market sale | 12 | $6.78 | $81 |
| 2025-07-22 | KPTI | Karyopharm Therapeutics Inc. | S — Open-market sale | 238 | $4.00 | $952 |
Kristin Abate is the Chief Accounting Officer at Karyopharm Therapeutics Inc., a pharmaceutical company focused on cancer therapies. She has been involved in multiple SEC filings related to her role, indicating her active participation in the company's financial reporting.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 8 open-market sales ($11K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Abate Kristin profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.